Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01528046
Title	Metformin in Children With Relapsed or Refractory Solid Tumors
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	H. Lee Moffitt Cancer Center and Research Institute
Indications	Advanced Solid Tumor
Therapies	Metformin Irinotecan + Temozolomide + Vincristine Sulfate
Age Groups:	child
Covered Countries	USA

Facility	City	State	Zip	Country	Details
Connecticut Children's Medical Center	Hartford	Connecticut	06106	United States	Details
Nemours/Alfred I. duPont Hospital for Children, Delaware	Wilmington	Delaware	19803	United States	Details
University of Florida	Gainesville	Florida	32611	United States	Details
Nemours Children's Clinic	Jacksonville	Florida	32207	United States	Details
University of Miami Sylvester Comprehensive Cancer Center	Miami	Florida	33136	United States	Details
Johns Hopkins All Children's Hospital	Saint Petersburg	Florida	33701	United States	Details
Tampa General Hospital	Tampa	Florida	33606	United States	Details
H. Lee Moffitt Cancer Center and Research Institute	Tampa	Florida	33612	United States	Details
University of Kentucky	Lexington	Kentucky	40536	United States	Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center	Baltimore	Maryland	21231	United States	Details
The Children's Hospital at Montefiore	Bronx	New York	10467	United States	Details
University of North Carolina at Chapel Hill	Chapel Hill	North Carolina	27599	United States	Details
Nationwide Children's Hospital	Columbus	Ohio	43205	United States	Details
Primary Children's Medical Center/Utah	Salt Lake City	Utah	84113	United States	Details

*Shaded cells indicate that there was no data available from clincialtrials.gov for the field